Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2770687003', 'doi': 'https://doi.org/10.1002/da.22702', 'title': 'Vortioxetine versus placebo in major depressive disorder comorbid with social anxiety disorder', 'display_name': 'Vortioxetine versus placebo in major depressive disorder comorbid with social anxiety disorder', 'publication_year': 2017, 'publication_date': '2017-11-22', 'ids': {'openalex': 'https://openalex.org/W2770687003', 'doi': 'https://doi.org/10.1002/da.22702', 'mag': '2770687003', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/29166552'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1002/da.22702', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S192592622', 'display_name': 'Depression and Anxiety', 'issn_l': '1091-4269', 'issn': ['1091-4269', '1520-6394'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'gold', 'oa_url': 'https://doi.org/10.1002/da.22702', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5032136657', 'display_name': 'Michael R. Liebowitz', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Michael R. Liebowitz', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5038516548', 'display_name': 'Jason M. Careri', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Jason Careri', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5013429056', 'display_name': 'Kyra Blatt', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Kyra Blatt', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5021753877', 'display_name': 'Ann Draine', 'orcid': 'https://orcid.org/0000-0002-9732-1059'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Ann Draine', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5030905048', 'display_name': 'Junko Morita', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Junko Morita', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5067681918', 'display_name': 'Melissa Moran', 'orcid': 'https://orcid.org/0009-0008-5461-0193'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Melissa Moran', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5008826821', 'display_name': 'Rita Hanover', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Rita Hanover', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 2300, 'currency': 'USD', 'value_usd': 2300, 'provenance': 'doaj'}, 'apc_paid': {'value': 2300, 'currency': 'USD', 'value_usd': 2300, 'provenance': 'doaj'}, 'fwci': 2.121, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 27, 'citation_normalized_percentile': {'value': 0.815577, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 92, 'max': 93}, 'biblio': {'volume': '34', 'issue': '12', 'first_page': '1164', 'last_page': '1172'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10853', 'display_name': 'Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/3205', 'display_name': 'Experimental and Cognitive Psychology'}, 'field': {'id': 'https://openalex.org/fields/32', 'display_name': 'Psychology'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10853', 'display_name': 'Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/3205', 'display_name': 'Experimental and Cognitive Psychology'}, 'field': {'id': 'https://openalex.org/fields/32', 'display_name': 'Psychology'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}, {'id': 'https://openalex.org/T11071', 'display_name': 'Treatment of Major Depression', 'score': 0.9996, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T13283', 'display_name': 'Mental Health Research Topics', 'score': 0.9976, 'subfield': {'id': 'https://openalex.org/subfields/3205', 'display_name': 'Experimental and Cognitive Psychology'}, 'field': {'id': 'https://openalex.org/fields/32', 'display_name': 'Psychology'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/vortioxetine', 'display_name': 'Vortioxetine', 'score': 0.88925683}], 'concepts': [{'id': 'https://openalex.org/C2778034309', 'wikidata': 'https://www.wikidata.org/wiki/Q3563148', 'display_name': 'Vortioxetine', 'level': 4, 'score': 0.88925683}, {'id': 'https://openalex.org/C2780051608', 'wikidata': 'https://www.wikidata.org/wiki/Q42844', 'display_name': 'Major depressive disorder', 'level': 3, 'score': 0.6970236}, {'id': 'https://openalex.org/C118552586', 'wikidata': 'https://www.wikidata.org/wiki/Q7867', 'display_name': 'Psychiatry', 'level': 1, 'score': 0.58257127}, {'id': 'https://openalex.org/C2777545354', 'wikidata': 'https://www.wikidata.org/wiki/Q3557657', 'display_name': 'Social anxiety', 'level': 3, 'score': 0.5717054}, {'id': 'https://openalex.org/C558461103', 'wikidata': 'https://www.wikidata.org/wiki/Q154430', 'display_name': 'Anxiety', 'level': 2, 'score': 0.5685382}, {'id': 'https://openalex.org/C15744967', 'wikidata': 'https://www.wikidata.org/wiki/Q9418', 'display_name': 'Psychology', 'level': 0, 'score': 0.53637266}, {'id': 'https://openalex.org/C70410870', 'wikidata': 'https://www.wikidata.org/wiki/Q199906', 'display_name': 'Clinical psychology', 'level': 1, 'score': 0.5067623}, {'id': 'https://openalex.org/C27081682', 'wikidata': 'https://www.wikidata.org/wiki/Q269829', 'display_name': 'Placebo', 'level': 3, 'score': 0.5056412}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.31421596}, {'id': 'https://openalex.org/C2780733359', 'wikidata': 'https://www.wikidata.org/wiki/Q331769', 'display_name': 'Mood', 'level': 2, 'score': 0.08607593}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.047730327}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D003865', 'descriptor_name': 'Depressive Disorder, Major', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D017063', 'descriptor_name': 'Outcome Assessment, Health Care', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D000072861', 'descriptor_name': 'Phobia, Social', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D017367', 'descriptor_name': 'Serotonin Uptake Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D013440', 'descriptor_name': 'Sulfides', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D000293', 'descriptor_name': 'Adolescent', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015897', 'descriptor_name': 'Comorbidity', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003865', 'descriptor_name': 'Depressive Disorder, Major', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003865', 'descriptor_name': 'Depressive Disorder, Major', 'qualifier_ui': 'Q000453', 'qualifier_name': 'epidemiology', 'is_major_topic': False}, {'descriptor_ui': 'D004311', 'descriptor_name': 'Double-Blind Method', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000072861', 'descriptor_name': 'Phobia, Social', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000072861', 'descriptor_name': 'Phobia, Social', 'qualifier_ui': 'Q000453', 'qualifier_name': 'epidemiology', 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D010919', 'descriptor_name': 'Placebos', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017367', 'descriptor_name': 'Serotonin Uptake Inhibitors', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D017367', 'descriptor_name': 'Serotonin Uptake Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013440', 'descriptor_name': 'Sulfides', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D013440', 'descriptor_name': 'Sulfides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000078784', 'descriptor_name': 'Vortioxetine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D055815', 'descriptor_name': 'Young Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1002/da.22702', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S192592622', 'display_name': 'Depression and Anxiety', 'issn_l': '1091-4269', 'issn': ['1091-4269', '1520-6394'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/29166552', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1002/da.22702', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S192592622', 'display_name': 'Depression and Anxiety', 'issn_l': '1091-4269', 'issn': ['1091-4269', '1520-6394'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.65, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 19, 'referenced_works': ['https://openalex.org/W1917104769', 'https://openalex.org/W1968692357', 'https://openalex.org/W1994095895', 'https://openalex.org/W2021153010', 'https://openalex.org/W2034849561', 'https://openalex.org/W2045208941', 'https://openalex.org/W2050531504', 'https://openalex.org/W2052782110', 'https://openalex.org/W2084170778', 'https://openalex.org/W2129162473', 'https://openalex.org/W2130648284', 'https://openalex.org/W2131823335', 'https://openalex.org/W2136485882', 'https://openalex.org/W2159775540', 'https://openalex.org/W2160070901', 'https://openalex.org/W2164855913', 'https://openalex.org/W2270496518', 'https://openalex.org/W2468100861', 'https://openalex.org/W4241727644'], 'related_works': ['https://openalex.org/W4254467278', 'https://openalex.org/W4237216922', 'https://openalex.org/W4226428375', 'https://openalex.org/W3208873205', 'https://openalex.org/W3044680332', 'https://openalex.org/W3021835408', 'https://openalex.org/W2902778000', 'https://openalex.org/W2757620833', 'https://openalex.org/W2401041180', 'https://openalex.org/W2023417500'], 'abstract_inverted_index': {'Depression': [0, 415], 'and': [1, 241, 245, 257, 264, 283, 298, 346, 402, 419, 435, 468, 498, 517], 'AnxietyVolume': [2], '34,': [3], 'Issue': [4], '12': [5], 'p.': [6], '1164-1172': [7, 569], 'RESEARCH': [8], 'ARTICLE': [9], 'Vortioxetine': [10], 'versus': [11], 'placebo': [12, 362, 460, 525], 'in': [13, 333, 338, 397, 399, 474, 480, 551], 'major': [14], 'depressive': [15], 'disorder': [16, 21], 'comorbid': [17, 504, 540], 'with': [18, 280, 502, 505, 507, 539], 'social': [19, 518], 'anxiety': [20], 'Michael': [22, 28, 34, 118, 124, 130], 'R.': [23, 29, 35, 119, 125, 131], 'Liebowitz': [24, 30, 120, 126, 420], 'MD,': [25, 37, 57, 68, 121, 133, 153, 164], 'Corresponding': [26, 122], 'Author': [27, 123], 'MD': [31, 127], '[email protected]': [32, 128], 'Correspondence': [33, 129], 'Liebowitz,': [36, 132], '134': [38, 134], 'East': [39, 135], '93rd': [40, 136], 'Street,': [41, 137], 'Suite': [42, 138], '201A,': [43, 139], 'New': [44, 140], 'York,': [45, 141], 'NY': [46, 142], '10128.': [47, 143], 'Email:': [48, 144], '[email protected]': [49, 145], 'for': [50, 61, 72, 83, 92, 101, 112, 146, 157, 168, 179, 188, 197, 208, 343, 500], 'more': [51, 62, 73, 84, 93, 102, 113, 147, 158, 169, 180, 189, 198, 209], 'papers': [52, 63, 74, 85, 94, 103, 114, 148, 159, 170, 181, 190, 199, 210], 'by': [53, 64, 75, 86, 95, 104, 115, 149, 160, 171, 182, 191, 200, 211], 'this': [54, 65, 76, 87, 96, 105, 116, 150, 161, 172, 183, 192, 201, 212, 278, 492, 545], 'authorJason': [55, 151], 'Careri': [56, 59, 152, 155], 'Jason': [58, 154], 'MDSearch': [60, 71, 156, 167], 'authorKyra': [66, 162], 'Blatt': [67, 70, 163, 166], 'Kyra': [69, 165], 'authorAnn': [77, 173], 'Draine,': [78, 174], 'Ann': [79, 175], 'Draine': [80, 176], 'orcid.org/0000-0002-9732-1059': [81, 177], 'Search': [82, 178], 'authorJunko': [88, 184], 'Morita,': [89, 185], 'Junko': [90, 186], 'MoritaSearch': [91, 187], 'authorMelissa': [97, 193], 'Moran,': [98, 194], 'Melissa': [99, 195], 'MoranSearch': [100, 196], 'authorRita': [106, 202], 'Hanover': [107, 110, 203, 206], 'PhD,': [108, 204], 'Rita': [109, 205], 'PhDSearch': [111, 207], 'author': [117, 213], 'First': [214], 'published:': [215], '22': [216], 'November': [217], '2017': [218], 'https://doi.org/10.1002/da.22702Citations:': [219], '20Read': [220], 'the': [221, 259, 269, 307, 386, 412, 427, 463, 527], 'full': [222, 233], 'textAboutPDF': [223], 'ToolsRequest': [224], 'permissionExport': [225], 'citationAdd': [226], 'to': [227, 249, 272, 314, 372, 486, 522], 'favoritesTrack': [228], 'citation': [229], 'ShareShare': [230], 'Give': [231], 'accessShare': [232, 235], 'text': [234], 'full-text': [236, 251, 275], 'accessPlease': [237], 'review': [238], 'our': [239], 'Terms': [240, 263], 'Conditions': [242, 265], 'of': [243, 253, 266, 277, 324, 357, 391, 431, 437, 514, 531, 537], 'Use': [244], 'check': [246], 'box': [247], 'below': [248, 271], 'share': [250, 273], 'version': [252, 276], 'article.I': [254], 'have': [255], 'read': [256], 'accept': [258], 'Wiley': [260], 'Online': [261], 'Library': [262], 'UseShareable': [267], 'LinkUse': [268], 'link': [270], 'a': [274, 289, 322, 352, 365, 446], 'article': [279], 'your': [281], 'friends': [282], 'colleagues.': [284], 'Learn': [285], 'more.Copy': [286], 'URL': [287], 'Share': [288], 'linkShare': [290], 'onFacebookTwitterLinkedInRedditWechat': [291], 'Abstract': [292], 'Background': [293], 'Major': [294, 405], 'Depressive': [295], 'Disorder': [296, 301, 336], '(MDD)': [297], 'Social': [299, 421], 'Anxiety': [300, 335, 422], '(SAD)': [302], 'are': [303, 542], 'highly': [304], 'comorbid,': [305], 'yet': [306], 'combined': [308], 'condition': [309], 'has': [310, 329], 'not': [311], 'been': [312], 'subject': [313], 'any': [315], 'placebo-controlled': [316, 355], 'treatment': [317], 'trials.': [318], 'This': [319], 'study': [320, 350, 369], 'reports': [321], 'trial': [323, 494], 'vortioxetine,': [325], 'an': [326], 'antidepressant': [327], 'that': [328], 'also': [330], 'shown': [331], 'benefit': [332], 'Generalized': [334], '(GAD),': [337], 'patients': [339, 441, 451, 501, 538], 'meeting': [340], 'DSM-5': [341], 'criteria': [342], 'both': [344, 400, 462, 515], 'MDD': [345, 401, 503], 'SAD.': [347, 481], 'Methods': [348], 'The': [349, 368, 382], 'was': [351, 370, 385, 476], '12-week': [353], 'double-blind,': [354], 'comparison': [356], 'vortioxetine': [358, 434, 495], '10–20': [359], 'mg/day': [360], 'or': [361, 376], 'administered': [363], 'on': [364, 411, 459, 461, 511, 526], '1:1': [366], 'ratio.': [367], 'designed': [371], 'include': [373], '40': [374], 'male': [375], 'female': [377], 'outpatients': [378], 'aged': [379], '18–70': [380], 'years.': [381], 'primary': [383, 528], 'endpoint': [384], '"composite"': [387], 'Clinical': [388], 'Global': [389], 'Impression': [390], 'Improvement': [392], '(CGI-I)': [393], 'responder': [394, 533], 'rate,': [395], 'factoring': [396], 'improvement': [398, 456, 479], 'SAD': [403], 'features.': [404], 'secondary': [406], 'outcome': [407, 529], 'measures': [408, 513], 'were': [409, 442, 484], 'changes': [410], 'Montgomery': [413], 'Asberg': [414], 'Rating': [416], 'Scale': [417, 423], '(MADRS)': [418], '(LSAS).': [424], 'Results': [425], 'On': [426], 'composite': [428, 532], 'CGI-I,': [429], '10': [430], '20': [432, 438], '(50%)': [433], 'six': [436], '(30%)': [439], 'placebo-treated': [440], 'rated': [443], 'as': [444, 544], 'responders,': [445], 'non-significant': [447], 'difference.': [448], 'However,': [449], 'vortioxetine-treated': [450], 'did': [452], 'show': [453], 'significantly': [454], 'greater': [455], 'than': [457], 'those': [458, 487], 'MADRS': [464], '(effect': [465, 470], 'size': [466, 471], '0.672)': [467], 'LSAS': [469], '0.714).': [472], 'Efficacy': [473], 'depression': [475, 516], 'seen': [477, 550], 'before': [478], 'Adverse': [482], 'effects': [483], 'similar': [485], 'previously': [488], 'reported.': [489], 'Conclusions': [490], 'In': [491], 'preliminary': [493], 'appears': [496], 'safe': [497], 'effective': [499], 'SAD,': [506], 'robust': [508], 'effect': [509], 'sizes': [510], 'dimensional': [512], 'anxiety,': [519], 'but': [520], 'failure': [521], 'separate': [523], 'from': [524], 'measure': [530], 'rate.': [534], 'More': [535], 'studies': [536], 'conditions': [541], 'needed,': [543], 'mirrors': [546], 'what': [547], 'is': [548], 'often': [549], 'clinical': [552], 'practice.': [553], 'Citing': [554], 'Literature': [555], 'Volume34,': [556], 'Issue12FOCUS': [557], 'ON:': [558], 'TREATMENT': [559], 'OF': [560], 'DEPRESSION': [561], 'AND': [562], 'ANXIETY:': [563], 'SWEATING': [564], 'THE': [565], 'SMALL': [566], 'STUFFDecember': [567], '2017Pages': [568], 'RelatedInformation': [570]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2770687003', 'counts_by_year': [{'year': 2024, 'cited_by_count': 3}, {'year': 2022, 'cited_by_count': 7}, {'year': 2021, 'cited_by_count': 6}, {'year': 2020, 'cited_by_count': 5}, {'year': 2019, 'cited_by_count': 4}, {'year': 2018, 'cited_by_count': 1}], 'updated_date': '2024-12-10T06:30:53.701621', 'created_date': '2017-12-04'}